Skip to main content
. Author manuscript; available in PMC: 2014 Dec 31.
Published in final edited form as: Gastroenterol Hepatol (Que). 2014;1(1):1–7. doi: 10.3968/5206

Figure 5. Western blotting analysis.

Figure 5

The data were expressed as relative values standardized by GAPDH. The expression of GCLM and GCLC in the dh404 treated group was significantly increased. However, there was no significant difference in other Nrf2 target antioxidants. There were no significant reduction of both NF-κB, COX-2 and eNOS expressions in the dh404-treated animals’ liver tissues